June 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountgvn.org
Global Rank
#2,312,846
200,200Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
34.85%
Pages per Visit
1.86
Avg Visit Duration
00:00:34
- Company
- - -
- Industry
- - -
Top 10 gvn.org Competitors
The Top 10 Sites Like gvn.org in June 2026 are ranked by their affinity to gvn.org in terms of keyword traffic, audience targeting, and market overlap
Background Coinfections of influenza A virus (IAV) and herpes simplex virus type 1 (HSV-1) have been increasingly reported in patients with severe pneumonia, yet their pathogenesis remains poorly understood. Methods We established murine models to investigate the effects of coinfection with HSV-1 (strain KOS) and IAV (A/Aichi/2/1968 (H3N2)) under different orders of infection. Mice were assigned to one of five groups: (1) HSV-1 monoinfection, (2) H3N2 monoinfection, (3) simultaneous coinfection (H3N2 + HSV-1), (4) sequential coinfection with H3N2 administered three days prior to HSV-1 (H3N2-HSV-1), and (5) sequential coinfection with HSV-1 administered three days prior to H3N2 (HSV-1-H3N2). We then compared disease severity, viral replication, lung injury, cytokine profiles along with innate and adaptive immune responses. Results Overall, all coinfection groups developed more severe disease than HSV-1 monoinfection. However, when compared to H3N2 monoinfection, the order of coinfection resulted in distinct differences in disease severity and immune response patterns. Specifically, simultaneous H3N2 + HSV-1 and sequential H3N2-HSV-1 coinfections led to increased mortality, higher H3N2 viral loads, and more pronounced pulmonary inflammation. These groups exhibited elevated cytokine levels and dysregulated immune responses, with the H3N2 + HSV-1 group displaying reduced proportions of natural killer cells (NK), plasmacytoid dendritic cells (pDCs) and interferon-producing killer dendritic cells (IKDCs) in bronchoalveolar lavage fluid (BALF), while the H3N2-HSV-1 group showed a robust expansion of these innate immune cells. Additionally, these two coinfection strategies were associated with increased H3N2-specific IFN-γ⁺CD8⁺ T cells, reflecting an exacerbated adaptive response. In contrast, sequential HSV-1-H3N2 coinfection resulted in milder disease manifestations, characterized by lower mortality, decreased clinical severity, reduced cytokine levels, and diminished pro
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
72.32%
Pages per Visit
1.15
Avg Visit Duration
00:00:03
Similarity Score
100%Outbreak.info explores COVID-19 and SARS-CoV-2 data with variant surveillance reports, data on cases and deaths, and a searchable research library.
- Company
- - -
- Industry
- - -
Global Rank
#3,282,929
441,146Bounce Rate
44.49%
Pages per Visit
1.57
Avg Visit Duration
00:00:13
Similarity Score
98%department of microbiology
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
89%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
83.33%
Pages per Visit
1.61
Avg Visit Duration
00:00:05
Similarity Score
87%Department of Microbiology, Genetics, & Immunology at Michigan State University
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
80%MacKenzie Scott disclosed on March 23, 2022, that she had given US$3.9 billion to 465 nonprofits in the previous nine months. These no-strings-attached donations bring the total she has given away in…
- Company
- - -
- Industry
- - -
Global Rank
#1,485,611
445,094Bounce Rate
47.05%
Pages per Visit
2.62
Avg Visit Duration
00:00:44
Similarity Score
74%dynavax technologies is focused on leveraging the power of the body’s innate and adaptive immune responses through toll-like receptor (tlr) stimulation.
Global Rank
#3,198,753
252,722Bounce Rate
38.94%
Pages per Visit
1.83
Avg Visit Duration
00:00:41
Similarity Score
71%Anivive's answers to frequently asked questions from investors
- Company
- - -
- Industry
- - -
Bounce Rate
55.32%
Pages per Visit
1.56
Avg Visit Duration
00:00:17
Similarity Score
68%Alle Neuigkeiten und bevorstehenden Veranstaltungen am Institut auf einen Blick.
Bounce Rate
54.91%
Pages per Visit
1.63
Avg Visit Duration
00:00:19
Similarity Score
65%Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, will present data on its COVID-19 prototype vaccine and its COVID-Influenza...
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
49.44%
Pages per Visit
1.76
Avg Visit Duration
00:02:14
Similarity Score
64%gvn.org's top 5 competitors in June 2026 are: virologyj.biomedcentral.com, outbreak.info, micro.med.upenn.edu, immunobiology.arizona.edu, and more.
According to Similarweb data of monthly visits, gvn.org’s top competitor in June 2026 is virologyj.biomedcentral.com. gvn.org 2nd most similar site is outbreak.info, and closing off the top 3 is micro.med.upenn.edu.
immunobiology.arizona.edu ranks as the 4th most similar website to gvn.org and mgi.natsci.msu.edu ranks fifth in June 2026.
The other five competitors in the top 10 list are dandavidprize.org, dynavax.com, anivive.com, helmholtz-hiri.de, and ir.novavax.com.